|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1989-10-6
|
|
pubmed:abstractText |
Our objective was to evaluate the impact of high-dose therapy and autologous bone marrow transplantation as salvage treatment for recurrent non-Hodgkin's lymphoma in a defined group of patients from the Nebraska Lymphoma Study Group.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
285-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:2672808-Adolescent,
pubmed-meshheading:2672808-Adult,
pubmed-meshheading:2672808-Aged,
pubmed-meshheading:2672808-Bone Marrow Transplantation,
pubmed-meshheading:2672808-Combined Modality Therapy,
pubmed-meshheading:2672808-Female,
pubmed-meshheading:2672808-Follow-Up Studies,
pubmed-meshheading:2672808-Humans,
pubmed-meshheading:2672808-Lymphoma, Non-Hodgkin,
pubmed-meshheading:2672808-Male,
pubmed-meshheading:2672808-Middle Aged,
pubmed-meshheading:2672808-Recurrence,
pubmed-meshheading:2672808-Remission Induction
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68105-1065.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
